Dexmedetomidine for monitored anesthesia care in patients undergoing liberation procedure for multiple sclerosis: An observational study

Saudi Journal of Anaesthesia

Volumn 6, Issue 4, 2012, Pages 358-362

  Anand, Saurabh ^a   Bhatia, Anshul ^a   Kumar, Raj ^a   Sapra, Harsh ^a   Gupta, Vipul ^b   Mehta, Yatin ^a  

^a Medanta the Medicity   (India)

^b Medanta Heart Institute   (India)

Author keywords

Dexmedetomidine; monitored anesthesia care; multiple sclerosis liberation procedure

Indexed keywords

ANESTHETIC AGENT; DEXMEDETOMIDINE; HEMOGLOBIN;

ADULT; ANESTHESIA INDUCTION; ANESTHESIA LEVEL; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEART RATE; HUMAN; LIBERATION PROCESS; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEDICAL PROCEDURES; MULTIPLE SCLEROSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OXYGEN SATURATION; PATIENT ASSESSMENT; PATIENT MONITORING; POSTOPERATIVE ANALGESIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEDATION; TREATMENT RESPONSE;

EID: 84873682892     PISSN: 1658354X     EISSN: 09753125     Source Type: Journal    
DOI: 10.4103/1658-354X.105865     Document Type: Article

References (23)

1. Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Tacconi G, Dall'Ara S, et al. Chronic cerebrospinal venous insufficiency in patients with MS. J Neurol Neurosurg Psychiatry 2009;80:392-9.
2. Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Gianesini S, Bartolomei I, et al. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous Insufficiency. J Vasc Surg 2009;50:1348-58.
3. Janzen PR, Christys A, Vucevic M. Patient-controlled sedation using propofol in elderly patients in day-case cataract surgery. Br J Anaesth 1999;82:635-6. (Pubitemid 29151251)
4. Weinbroum AA, Szold O, Ogorek D, Flaishon R. The midazolam-induced paradox phenomenon is reversible by flumazenil. Epidemiology, patient characteristics and review of the literature. Eur J Anaesthesiol 2001;18:789-97. (Pubitemid 33071092)
5. Wong DH, Merrick PM. Intravenous sedation prior to peribulbar anaesthesia for cataract surgery in elderly patients. Can J Anaesth 1996;43:1115-20. (Pubitemid 27063905)
6. A lhashemi JA, Kaki AM. Dexmedetomidine in combination with morphine PCA provides superior analgesia for shockwave lithotripsy. Can J Anaesth 2004;51:342-7. (Pubitemid 38701942)
7. R amsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974;2:656-9.
8. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use. Oxford: Oxford University Press; 1995 .p. 28-53.
9. Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000;4:302-8.
10. Scheinin B, Lindgren L, Randell T, Scheinin H, Scheinin M. Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and perioperative fentanyl. Br J Anaesth 1992;68:126-31.
11. Cortinez LI, Hsu YW, Sum-Ping ST. Dexmedetomidine pharmacodynamics: Part II . Crossover comparison of the analgesia effect of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 2004;101:1077-83. (Pubitemid 39430786)
12. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000;90:699-705. (Pubitemid 30117535)
13. Arain SR, Ebert TJ. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg 2002;95:461-6. (Pubitemid 34793121)
14. Scheinin H, Karhuvaara S, Olkkola KT, Kallio A, Anttila M, Vuorilehto L, et al. Pharmacodynamics and pharmacokinetics of intramuscular dexmedetomidine. Clin Pharmacol Ther 1992;52:537-4.
15. Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine: A review of clinical applications. Curr Opin Anaesthesiol 2008;21:457-61.
16. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 1992;77:1125-33. (Pubitemid 23001123)
17. Venn RM, Grounds RM. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: Patient and clinical perceptions. Br J Anaesth 2001;87:684-90. (Pubitemid 33069556)
18. Elbaradie S, El Mahalawy FH, Solyman AH. Dexmedetomidine vs. propofol for short-term sedation of postoperative mechanically ventilated patients. J Egypt Natl Canc Inst 2004;16:153-8.
19. A bdalla MI, Al Mansouri F, Bener A. Dexmedetomidine during local anesthesia. J Anesth 2006;20:54-6.
20. T aghinia AH, Shapiro FE, Slavin SA. Dexmedetomidine in aesthetic facial surgery: Improving anesthetic safety and efficacy. Plast Reconstr Surg 2008;121:269-76.
21. Soliman RN, Hassan AR, Rashwan AM, Omar AM. Prospective, randomized controlled study to assess the role of dexmedetomidine in patients with supratentorial tumors undergoing craniotomy under general anesthesia. Middle East J Anesthesiol 2011;21:23-33.
22. Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists: Their pharmacology and therapeutic role. Anaesthesia 1999;54:146-65. (Pubitemid 29057426)
23. Guo T-Z, Jiang J-Y, Buttermann AE, Maze M. Dexmedetomidine injection into the locus coeruleus produces antinociception. Anesthesiology 1997;84:873-81. (Pubitemid 26106212)